Mass spectrometric characterization of modifications to angiotensin II by lipid peroxidation products, 4-oxo-2(E)-nonenal and 4-hydroxy-2(E)-nonenal

Chemical Research in Toxicology

Volumn 23, Issue 11, 2010, Pages 1771-1785

  Lee, Seon Hwa ^a   Takahashi, Ryo ^a   Goto, Takaaki ^a   Oe, Tomoyuki ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; 4 OXO 2(E) NONENAL; ALDEHYDE DERIVATIVE; ANGIOTENSIN II; ARGININE; ASPARTIC ACID; CARBOXYLIC ACID; HISTIDINE; NUCLEOPHILE; SODIUM BOROHYDRIDE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHEMICAL REACTION; DECARBOXYLATION; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICHAEL ADDITION; PROTEIN CONFORMATION; PROTEIN MODIFICATION; TANDEM MASS SPECTROMETRY;

ALDEHYDES; AMINO ACID SEQUENCE; ANGIOTENSIN II; BOROHYDRIDES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; LIPID PEROXIDATION; OLIGOPEPTIDES; OXIDATION-REDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS;

EID: 78649250987     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx100228q     Document Type: Article

References (55)

1. Campbell, D. J. (1987) Circulating and tissue angiotensin systems J. Clin. Invest. 79, 1-6
2. Dzau, V. J., Kristin, E. E., Brody, T., Ingelfinger, J., and Pratt, R. E. A. (1987) Comparative study of the distributions of renin and angiotensinogen messenger ribonucleic acids in rat and in mouse and in rat tissues Endocrinology 120, 2334-2338
3. Culman, J., Baulmann, J., Blume, A., and Unger, T. (2001) The renin-angiotensin system in the brain: an update J. Renin Angiotensin Aldosterone Syst. 2, 96-102
4. Fyhrquist, F. and Saijonmaa, O. (2008) Renin-angiotensin system revisited J. Intern. Med. 264, 224-236
5. Suzuki, H., Frank, G. D., Utsunomiya, H., Higuchi, S., and Eguchi, S. (2006) Current understanding of the mechanism and role of ROS in angiotensin II signal transduction Curr. Pharm. Biotechnol. 7, 81-86
6. Griendling, K. K. and Ushio-Fukai, M. (2000) Reactive oxygen species as mediators of angiotensin II signaling Regul. Pept. 91, 21-27
7. Touyz, R. M. (2004) Reactive oxygen species and angiotensin II signaling in vascular cells: implications in cardiovascular disease Braz. J. Med. Biol. Res. 37, 1263-1273
8. Garrido, A. M. and Griendling, K. K. (2009) NADPH oxidases and angiotensin II receptor signaling Mol. Cell. Endocrinol. 302, 148-158
9. Ohtsu, H., Frank, G. D., Utsunomiya, H., and Eguchi, S. (2005) Redox-dependent protein kinase regulation by angiotensin II: mechanistic insights and its pathophysiology Antioxid. Redox. Signaling 7, 1315-1326
10. Lee, S. H., Oe, T., and Blair, I. A. (2001) Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins Science 292, 2083-2086
11. Sayre, L. M., Lin, D., Yuan, Q., Zhu, X., and Tang, X. (2006) Protein adducts generated from products of lipid oxidation: focus on HNE and ONE Drug Metab. Rev. 38, 651-675
12. Lee, S. H., Rindgen, D., Jr., Hajdu, E., and Blair, I. A. (2000) Characterization of 2′-deoxyadenosine adducts derived from 4-oxo-2-nonenal, a novel product of lipid peroxidation Chem. Res. Toxicol. 13, 565-574
13. Lee, S. H., Williams, M. V., Dubois, R. N., and Blair, I. A. (2005) Cyclooxygenase-2-mediated DNA damage J. Biol. Chem. 280, 28337-28346
14. Williams, M. V., Lee, S. H., Pollack, M., and Blair, I. A. (2006) Endogenous lipid hydroperoxide-mediated DNA-adduct formation in min mice J. Biol. Chem. 281, 10127-10133
15. Marnett, L. J. and Plastaras, J. P. (2001) Endogenous DNA damage and mutation Trends Genet. 17, 214-221
16. Blair, I. A. (2008) DNA adducts with lipid peroxidation products J. Biol. Chem. 283, 15545-15549
17. Grimsrud, P. A., Xie, H., Griffin, T. J., and Bernlohr, D. A. (2008) Oxidative stress and covalent modification of protein with bioactive aldehydes J. Biol. Chem. 283, 21837-21841
18. Oe, T., Arora, J. S., Lee, S. H., and Blair, I. A. (2003) A novel lipid hydroperoxide-derived cyclic covalent modification to histone H4 J. Biol. Chem. 278, 42098-42105 (Pubitemid 37310476)
19. Carini, M., Aldini, G., and Facino, R. M. (2004) Mass spectrometry for detection of 4-hydroxy- trans -2-nonenal (HNE) adducts with peptides and proteins Mass Spectrom. Rev. 23, 281-305
20. Oe, T., Lee, S. H., Silva Elipe, M. V., Arison, B. H., and Blair, I. A. (2003) A novel lipid hydroperoxide derived modification to arginine Chem. Res. Toxicol. 16, 1598-1605
21. Lee, S. H., Goto, T., and Oe, T. (2008) A novel 4-oxo-2(E)-nonenal- derived modification to angiotensin II: oxidative decarboxylation of N-terminal aspartic acid Chem. Res. Toxicol. 21, 2237-2244
22. Doorn, J. A., Hurley, T. D., and Petersen, D. R. (2006) Inhibition of human mitochondrial aldehyde dehydrogenase by 4-hydroxynon-2-enal and 4-oxonon-2-enal Chem. Res. Toxicol. 19, 102-110
23. Stewart, B. J., Doorn, J. A., and Petersen, D. R. (2007) Residue-specific adduction of tubulin by 4-hydroxynonenal and 4-oxononenal causes cross-linking and inhibits polymerization Chem. Res. Toxicol. 20, 1111-1119
24. Roede, J. R., Carbone, D. L., Doorn, J. A., Kirichenko, O. V., Reigan, P., and Petersen, D. R. (2008) In vitro and in silico characterization of peroxiredoxin 6 modified by 4-hydroxynonenal and 4-oxononenal Chem. Res. Toxicol. 21, 2289-2299
25. 2, HOONO)-evaluation by mass spectrometry Eur. J. Biochem. 253, 146-153
26. Lee, S. J., Lee, J. R., Kim, Y. H., Park, Y. S., Park, S. I., Park, H. S., and Kim, K. P. (2007) Investigation of tyrosine nitration and nitrosylation of angiotensin II and bovine serum albumin with electrospray ionization mass spectrometry Rapid Commun. Mass Spectrom. 21, 2797-2804
27. Uchida, K. and Kawakishi, S. (1990) Site-specific oxidation of angiotensin I by copper(II) and L-ascorbate: conversion of histidine residues to 2-imidazolones Arch. Biochem. Biophys. 283, 20-26
28. Tzakos, A. G., Gerothanassis, I. P., and Troganis, A. N. (2004) On the structural basis of the hypertensive properties of angiotensin II: a solved mystery or a controversial issue? Curr. Top. Med. Chem. 4, 431-444
29. 1) J. Biol. Chem. 270, 14024-14030
30. 1 receptor is essential for full agonism J. Biol. Chem. 270, 12846-12850
31. Khosla, M. C., Hall, M. M., Smeby, R. R., and Bumpus, F. M. (1973) Factors that influence the antagonistic properties of angiotensin II antagonists J. Med. Chem. 16, 829-832
32. Needleman, P., Marshall, G. R., and Rivier, J. (1973) Angiotensin II. synthesis and biological activity of 6-(1-methylhistidine) and 6-(3-methylhistidine) analogs J. Med. Chem. 16, 968-970
33. Liu, Z., Minkler, P. E., and Sayre, L. M. (2003) Mass spectroscopic characterization of protein modification by 4-hydroxy-2-(E)-nonenal and 4-oxo-2-(E)-nonenal Chem. Res. Toxicol. 16, 901-911
34. Zhu, X. and Sayre, L. M. (2007) Long-lived 4-oxo-2-enal-derived apparent lysine Michael adducts are actually the isomeric 4-ketoamides Chem. Res. Toxicol. 20, 165-170
35. Esterbauer, H., Schaur, R. J., and Zollner, H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Radical Biol. Med. 11, 81-128
36. Matsui, T., Tamaya, K., Matsumoto, K., Osajima, Y., Uezono, K., and Kawasaki, T. (1999) Plasma concentrations of angiotensin metabolites in young male normotensive and mild hypertensive subjects Hypertens. Res. 22, 273-277
37. Lee, K. W., Lip, G. Y., and Blann, A. D. (2004) Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes Circulation 110, 2355-2360
38. David, S., Kümpers, P., Lukasz, A., Kielstein, J. T., Haller, H., and Fliser, D. (2009) Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/pravastatin J. Hypertens. 27, 1641-1647
39. Kobori, H., Nangaku, M., Navar, L. G., and Nishiyama, A. (2007) The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease Pharmacol. Rev. 59, 251-287
40. Lin, D., Lee, H. G., Liu, Q., Perry, G., Smith, M. A., and Sayre, L. M. (2005) 4-Oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-hydroxy-2-nonenal Chem. Res. Toxicol. 18, 1219-1231
41. Doorn, J. A. and Petersen, D. R. (2002) Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal Chem. Res. Toxicol. 15, 1445-1450
42. Chen, Q., Esterbauer, H., and Jürgens, G. (1992) Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal: Biochemical characterization and determination Biochem. J. 15, 249-254
43. Isom, A. L., Barnes, S., Wilson, L., Kirk, M., Coward, L., and Darley-Usmar, V. (2004) Modification of Cytochrome c by 4-hydroxy-2-nonenal: evidence for histidine, lysine, and arginine-aldehyde adducts J. Am. Soc. Mass Spectrom. 15, 1136-1147
44. Uchida, K. and Stadtman, E. R. (1992) Modification of histidine residues in proteins by reaction with 4-hydroxynonenal Proc. Natl. Acad. Sci. U.S.A. 89, 4544-4548
45. Nadkarni, D. V. and Sayre, L. M. (1995) Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal Chem. Res. Toxicol. 8, 284-291
46. Hashimoto, M., Sibata, T., Wasada, H., Toyokuni, S., and Uchida, K. (2003) Structural basis of protein-bound endogenous aldehydes: Chemical and immunochemical characterizations of configurational isomers of a 4-hydroxy-2-nonenal-histidine adduct J. Biol. Chem. 14, 5044-5051
47. Winter, D., Pipkorn, R., and Lehmann, W. D. (2009) Separation of peptide isomers and conformers by ultra performance liquid chromatography J. Sep. Sci. 32, 1111-1119
48. 1]angiotensin II on conformation and activity: NMR evidence for aromatic ring clustering and peptide backbone folding compared with [des-1,2,3]angiotensin II J. Biol. Chem. 269, 5303-5312
49. Matsoukas, J. M., Polevaya, L., Ancans, J., Mavromoustakos, T., Kolocouris, A., Roumelioti, P., Vlahakos, D. V., Yamdagni, R., Wu, Q., and Moore, G. J. (2000) The design and synthesis of a potent Angiotensin II cyclic analogue confirms the ring cluster receptor conformation of the hormone Angiotensin II Bioorg. Med. Chem. 8, 1-10
50. Tzakos, A. G., Gerothanassis, I. P., and Troganis, A. N. (2004) On the structural basis of the hypertensive properties of angiotensin II: a solved mystery or a controversial issue? Curr. Top. Med. Chem. 4, 431-444
51. Sayre, L. M., Arora, P. K., Iyer, R. S., and Salomon, R. G. (1993) Pyrrole formation from 4-hydroxynonenal and primary amines Chem. Res. Toxicol. 6, 19-22
52. Sayre, L. M., Sha, W., Xu, G., Kaur, K., Nadkarni, D., Subbanagounder, G., and Salomon, R. G. (1996) Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenal Chem. Res. Toxicol. 9, 1194-1201
53. Cesari, M., Rossi, G. P., and Pessina, A. C. (2002) Biological properties of the angiotensin peptides other than angiotensin II: implications for hypertension and cardiovascular diseases J. Hypertens. 20, 793-799
54. Wright, J. W., Tamura-Myers, E., Wilson, W. L., Roques, B. P., Llorens-Cortes, C., Speth, R. C., and Harding, J. W. (2003) Conversion of brain angiotensin II to angiotensin III is critical for pressor response in rats Am. J. Physiol. 284, R725-R733
55. Jankowski, V., Vanholder, R., van der Giet, M., Tölle, M., Karadogan, S., Gobom, J., Furkert, J., Oksche, A., Krause, E., Tran, T. N., Tepel, M., Schuchardt, M., Schlüter, H., Wiedon, A., Beyermann, M., Bader, M., Todiras, M., Zidek, W., and and Jankowski, J. (2007) Mass-spectrometric identification of a novel angiotensin peptide in human plasma Arterioscler., Thromb., Vasc. Biol. 27, 297-302